Skip to contentR
Rigel Pharmaceuticals Inc
R
RIGLRigel Pharmaceuticals Inc Released Aug 4, 2015, after the close
10-Q filed Aug 4, 2015, 35 days after period end · 0001104659-15-055877
Q2 2015 · 10-Q
Revenue—
Net income—
EPS Diluted-$0.16-$0.16N/M vs Q2 2014 No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
N/M vs Q1 2015
Operating Income-$13,974,000N/M Operating Cash Flowderived-$18,146,000N/M Free Cash Flowderived-$18,219,000N/M ended Jun 30, 2015 · filed Aug 4, 2015 · 35 d after period end
+1.6% from the close of Aug 4, 2015 to the close of Aug 5, 2015, the first after the release.
after the close$3.16$3.21 Jun 16Aug 4Sep 1